Latest filing published 25 Sept 2023 for abrdn Healthcare Investors, €140k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 43 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +19.1%Entry US$15.52 · Close at T+365 US$18.48
- +21.5%Entry US$12.38 · Close at T+365 US$15.04
- +24.9%Entry US$12.45 · Close at T+365 US$15.55
- +20.7%Entry US$15.57 · Close at T+365 US$18.80
- -24.8%Entry US$21.70 · Close at T+365 US$16.31
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Daniel R. Omstead: trading record in brief
Filings by Daniel R. Omstead span 4 companies, the busiest being abrdn Healthcare Investors, abrdn Life Sciences Investors and abrdn Healthcare Opportunities Fund. The record holds 46 filings, for trades running from 28 September 2006 to 25 September 2023.
Purchases make up the whole of the open-market record (43 purchases, €2.9M). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants. In 2023 alone, the filings show 4 purchases and no sales.
In size, the median ticket on the buying side is €87k. 2 out of 23 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 43 purchases old enough to measure, the stock rose over the following 90 days in 60% of cases; the median change was +2.8%. These figures describe past trades and do not predict future prices.
The newest entry dates from 25 September 2023: an open-market purchase of €140k, in abrdn Healthcare Investors. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Daniel R. Omstead
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,500 shares@ US$15.633249.8% of flowShares of Beneficial InterestSEC:0001104659-23-103574:0Canonical exit: 24 Dec 2023 (T+90)
- 10,096 shares@ US$12.392631.2% of flowShares of Beneficial InterestSEC:0001104659-23-103576:0Canonical exit: 24 Dec 2023 (T+90)
- 9,500 shares@ US$15.876750.2% of flowShares of Beneficial InterestSEC:0001104659-23-102458:0Canonical exit: 19 Dec 2023 (T+90)
- 12,000 shares@ US$12.683837.7% of flowShares of Beneficial InterestSEC:0001104659-23-102460:0Canonical exit: 19 Dec 2023 (T+90)
- 6,403 shares@ US$21.6331.1% of flowShares of Beneficial InterestSEC:0001104659-21-103959:0Canonical exit: 9 Nov 2021 (T+90)
- 6,442 shares@ US$14.2629.2% of flowShares of Beneficial InterestSEC:0001104659-21-048071:0
- 5,200 shares@ US$20.527713.8% of flowShares of Beneficial InterestSEC:0001104659-20-118219:0Canonical exit: 24 Jan 2021 (T+90)
- 6,175 shares@ US$17.522912.1% of flowShares of Beneficial InterestSEC:0001104659-20-118221:0Canonical exit: 24 Jan 2021 (T+90)
- 5,050 shares@ US$20.678713.5% of flowShares of Beneficial InterestSEC:0001104659-20-116859:0Canonical exit: 19 Jan 2021 (T+90)
- 5,950 shares@ US$17.748911.8% of flowShares of Beneficial InterestSEC:0001104659-20-116861:0Canonical exit: 19 Jan 2021 (T+90)
- 5,950 shares@ US$17.7412.8% of flowShares of Beneficial InterestSEC:0001104659-20-065199:0Canonical exit: 19 Aug 2020 (T+90)
- 5,000 shares@ US$21.0114.6% of flowShares of Beneficial InterestSEC:0001104659-20-065198:0Canonical exit: 19 Aug 2020 (T+90)
- 6,800 shares@ US$16.2415.1% of flowShares of Beneficial InterestSEC:0001104659-20-034865:0Canonical exit: 15 Jun 2020 (T+90)
- 9,926 shares@ US$10.77100.0% of flowShares of Beneficial InterestSEC:0001104659-20-034864:0Canonical exit: 15 Jun 2020 (T+90)
- 7,300 shares@ US$14.67100.0% of flowShares of Beneficial InterestSEC:0001104659-20-034867:0Canonical exit: 15 Jun 2020 (T+90)
- 8,300 shares@ US$13.2713.1% of flowShares of Beneficial InterestSEC:0001104659-20-034866:0Canonical exit: 15 Jun 2020 (T+90)
- 6,300 shares@ US$17.1410.3% of flowShares of Beneficial InterestSEC:0001104659-18-074725:0Canonical exit: 26 Mar 2019 (T+90)
- 9,400 shares@ US$11.1148.9% of flowShares of Beneficial InterestSEC:0001104659-18-074724:0Canonical exit: 26 Mar 2019 (T+90)
- 6,000 shares@ US$17.4320.3% of flowShares of Beneficial InterestSEC:0001104659-18-063921:0Canonical exit: 23 Jan 2019 (T+90)
- 5,500 shares@ US$20.4310.7% of flowShares of Beneficial InterestSEC:0001104659-18-063922:0Canonical exit: 23 Jan 2019 (T+90)
- 5,902 shares@ US$18.1920.7% of flowShares of Beneficial InterestSEC:0001104659-18-062504:0Canonical exit: 15 Jan 2019 (T+90)
- 3,882 shares@ US$21.788.0% of flowShares of Beneficial InterestSEC:0001104659-18-062503:0Canonical exit: 15 Jan 2019 (T+90)
- 5,500 shares@ US$17.5918.5% of flowShares of Beneficial InterestSEC:0001104659-18-061572:0Canonical exit: 9 Jan 2019 (T+90)
- 5,500 shares@ US$18.2719.3% of flowShares of Beneficial InterestSEC:0001104659-18-061368:0Canonical exit: 8 Jan 2019 (T+90)
- 5,000 shares@ US$20.00Shares of Beneficial InterestSEC:0001104659-15-047942:0Canonical exit: 23 Sept 2015 (T+90)
25 of 46 declarations